Clinical trial
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When…
NCT00412516 · PATH, Other · Completed
Key facts
| NCT number | NCT00412516 |
|---|---|
| Title | Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine |
| Official title | Long-Term Assessment at 24 Months Post-Vaccination of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine to Measles Vaccine Given Alone |
| Lead sponsor | PATH, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Encephalitis, Japanese B |
| Intervention type | Biological |
| Interventions | Live attenuated SA 14-14-2 vaccine |
| Enrollment | 519 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Dec 18, 2006 |
| Last update posted | Oct 13, 2014 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: